• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Apheresis Equipment - Global Strategic Business Report Product Image

Apheresis Equipment - Global Strategic Business Report

  • ID: 338516
  • February 2015
  • Region: Global, United States
  • 214 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousands by the following Types: Equipment for Therapeutic Apheresis, and Equipment for Donor Apheresis. Global market is analyzed by the following Applications: Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as :

- Asahi Kasei Medical Co., Ltd
- B Braun Melsungen AG
- Cerus Corporation
- Fresenius Kabi
- Haemonetics Corporation

Note: Product cover images may vary from those shown

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Prelude
Donor Apheresis: Dominating Equipment Sales
Table 1: Active Donors of Whole Blood and Apheresis per 1,000 Population by Country/Agency (2012) (includes corresponding Graph/Chart)
Table 2: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (2012) (includes corresponding Graph/Chart)
Therapeutic Apheresis to Witness Strong Growth
Developed Markets Lead, Developing Nations to Lead the Charge in Future
Rising Demand for Plasma from Biopharmaceutical Companies
Opportunity to Tap
Sustained Growth in Blood Collections Favors Apheresis Equipment Market
Table 3: Total Blood Collections (2014): Percentage Share Breakdown of Collections (Units) by Segment
Whole Blood and Apheresis (includes corresponding Graph/Chart)
Table 4: Total Blood Collections (2014): Percentage Share Breakdown of Collections (Units) for Leukoreduced and Non-Leukoreduced Blood (includes corresponding Graph/Chart)
Competitive Landscape
Table 5: Leading Players in the Global Apheresis Systems Market (2013): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart)
Table 6: Leading Players in the Global Blood Component Collection Market (2013E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo Corp and Others (includes corresponding Graph/Chart)
Terumo Banks on Growing Apheresis Market
Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers

2. KEY MARKET TRENDS & DRIVERS
Rising Cancer Incidence to Drive Volume of Apheresis Procedures
Table 7: Worldwide Incidence of Cancer (2013, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
Table 8: World Cancer Incidence (2012): Number of New Cancer Cases Reported (in Thousands) by Geographic Region and Gender (includes corresponding Graph/Chart)
Table 9: World Cancer Mortality (2012): Number of Cancer-Related Deaths (in Thousands) by Geographic Region and Gender (includes corresponding Graph/Chart)
Table 10: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)
Technological Advancements and Novel Indications Augur Well for Apheresis Market
Blood Supply Shortage & Safety Concerns Bode Well for Apheresis Market
Photopheresis: A Popular Therapeutic Apheresis Procedure
Plasmapheresis Continues to Lead the Apheresis Market
Table 11: Plasma Collection Methods: Percentage Share Breakdown by Fractionation and Extraction from Whole Blood (2013 Vs. 2010) (includes corresponding Graph/Chart)
Plateletpheresis Emerges as the ‘Treatment of Choice’
Increase in Number of Platelet Donors Drives Apheresis Procedures
Pediatrics: An Unexplored Domain in Therapeutic Apheresis
Automated Blood Processing Systems in Open Heart Surgeries
CFA
An Effective Way to Pull Up Cold Hemagglutinin Disease
Improving Healthcare Expenditure to Drive Demand
Table 12: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
Table 13: Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)
Aging Population: A Strong Growth Driver
Table 14: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
Table 15: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
Table 16: Life Expectancy at Age 60 and 80 Years
(2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
Key Challenges & Issues
Lack of Awareness among Patients Restrains Market Growth
Vendors’ Attitude Hampers Growth Prospects of Therapeutic Apheresis
Development of Inexpensive Apheresis Therapies
Scarcity of Qualified Donors
Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment

3. TECHNOLOGY OVERVIEW
Apheresis
The Definition
Apheresis Vs Whole Blood Collection
Comparison of Apheresis and Whole Blood Collection
The Process of Apheresis
An Overview
Blood Components
Apheresis Procedure
Duration, Frequency, and Efficiency of Apheresis
Segregation of Blood Components
Centrifugation
Centrifugal Cell Separators
Filtration
Side Effects
Types of Apheresis Procedures
Plasmapheresis
Plasma Exchange and Plasmapheresis: The Difference
Therapeutic Plasma Exchange (TPE) or Plasma Exchange
TPE: Abnormal Components Removed from Blood
Plasmapheresis: Potential Uses Discovered in the Early Years
Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
Erythrocytapheresis
Plateletpheresis
Leukapheresis
Photopheresis
Functioning of THERAKOS™
A Typical Photopheresis System
Lipidpheresis
Cytapheresis
Stem Cell Collection
Apheresis
A Review of Segmentation
Donor Apheresis
Process of Donor Apheresis
Automated Blood Donation Procedures
Safety of the Donor
Blood Components Required by Different Patients
Automated Apheresis
Therapeutic Apheresis: An Introduction
Therapeutic Apheresis Techniques
Applications of Therapeutic Apheresis
Categories of Indications for Therapeutic Apheresis
Therapeutic Apheresis is Remedial for Various Diseases
Indications for Therapeutic Apheresis
Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
Emerging Applications of Therapeutic Apheresis
Cost of Select Therapeutic Apheresis Procedures: An Overview
1. Photopheresis in GVHD (Graft-Versus-Host Disease)
2. Lipid Apheresis (LDL Apheresis)
3. Plasmapheresis and Other Procedures
Therapeutic Apheresis: What is the Risk Involved?
Replacement Fluid in Therapeutic Apheresis
Replacement Fluids Used in Therapeutic Apheresis
Various Replacement Fluids in Use
Select Replacement Fluids and their Limitations
Table 17: Fluid Balance in Fluid Replacement
Table 18: Volume Exchange of Plasma Constituents (includes corresponding Graph/Chart)
Table 19: Removal of IgM and IgG by Plasma Exchange Volume (includes corresponding Graph/Chart)
Table 20: Therapeutic Apheresis: Percentage Decrease and Restoration of Blood Components
Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement

4. BLOOD COMPONENTS & DERIVATIVES
Red Blood Cells (RBCs)
White Blood Cells (WBCs)
Platelets
Sources of Blood Plasma
Facts About Plasma and its Donation
Pre-requisites for Plasma Donors
The Complex Process of Becoming a Donor
Medical Screening
The Process of Plasma Donation
Select IQPP-authorized Plasma Collection Centers (US)
Ionic Composition of Blood
Types of Blood
General Facts about Blood
General Uses of Blood
Blood
Global Facts

5. PRODUCT DEVELOPMENTS/APPROVALS
FDA Approves IDE Supplement for Cerus’ INTERCEPT Blood System
Health Canada Approves WBCD and PMN Cell Collection Protocols for Spectra Optia
USFDA Clears PMN Protocol for Terumo’s Spectra Optia
Fenwal’s Aurora Plasmapheresis System Receives 60601-1 3rd Edition Certification
Terumo BCT Receives 510(k) FDA Clearance for RBCX On Spectra Optia
Health Canada Clears BMP Protocol on Terumo’s Spectra Optia
Terumo BCT Receives FDA Approval for Enhancement to MNC Collection Protocol for Spectra Optia System
Fenwal Unveils Aurora™ Plasmapheresis System
Terumo BCT Introduces MNC Collection Protocol for Spectra Optia System
Terumo BCT Unveils New Therapeutic Apheresis Capabilities and Procedures
Terumo BCT Obtains FDA Approval for PF24 and PF24RT24 on TrimaAccel System
Fenwal Secures US FDA Approval for Therapeutic Plasma Exchange Protocol on Amicus® Separator

6. RECENT INDUSTRY ACTIVITY
Terumo BCT Files FDA Submission to Improve Blood Supply Safety
Fenwal Autopheresis-C Instruments Donated for Ebola Virus Study
Terumo opens Production Facility in Vietnam
Terumo Collaborates with Kaneka
Terumo to Distribute Therakos Products in Latin America
Terumo Enters Distribution Agreement with Therakos
The Gores Group Acquires Therakos from Ortho-Clinical Diagnostics
Terumo BCT to Acquire Medservice
Fresenius Kabi Acquires Fenwal Holdings
CaridianBCT Collaborates with Terumo Transfusion to Form Terumo BCT
Cerus to Enter into Partnership with BSI and American Red Cross to Commercialize INTERCEPT Plasma

7. FOCUS ON SELECT GLOBAL PLAYERS
Asahi Kasei Medical Co., Ltd. (Japan)
B Braun Melsungen AG (Germany)
Cerus Corporation (US)
Fresenius Kabi (Germany)
Fenwal, Inc. (US)
Haemonetics Corporation (US)
HemaCare Corp. (US)
Kaneka Corporation (Japan)
Kawasumi Laboratories, Inc. (Japan)
Medica SpA (Italy)
NIKKISO Europe GmbH (Germany)
Terumo BCT, Inc. (US)
Therakos, Inc. (US)

8. GLOBAL MARKET PERSPECTIVE
Table 21: World Recent Past, Current & Future Analysis for Apheresis Equipment Market by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 22: World Historic Review for Apheresis Equipment Market by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 23: World 14-Year Perspective for Apheresis Equipment Market by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 24: World Recent Past, Current & Future Analysis for Equipment for Therapeutic Apheresis by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 25: World Historic Review for Equipment for Therapeutic Apheresis by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 26: World 14-Year Perspective for Equipment for Therapeutic Apheresis by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 27: World Recent Past, Current & Future Analysis for Equipment for Donor Apheresis by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 28: World Historic Review for Equipment for Donor Apheresis by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 29: World 14-Year Perspective for Equipment for Donor Apheresis by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 30: World Recent Past, Current & Future Analysis for Apheresis Equipment by Procedure Type
Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 31: World Historic Review for Apheresis Equipment by Procedure Type
Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 32: World 14-Year Perspective for Apheresis Equipment by Procedure Type
Percentage Breakdown of Dollar Sales for Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Current & Future Analysis
Apheresis Market
An Overview
Opportunity Indicator:
Table 33: US Market for Blood Collection by Type (2015E): Percentage Breakdown of Apheresis and Whole Blood Collection Procedures for Platelets and RBC (includes corresponding Graph/Chart)
Blood Donations
Table 34: Blood Transfusions per 1000 population in the US (2012-2017) (includes corresponding Graph/Chart)
Blood Supply and Demand in the US
A Fact Sheet
Criteria for Platelet Donation
Criteria for Double Red Cell Donation
Plasma Donations
Table 35: Number of Plasma Donations Required Annually by Disease Type in the US (2012) (includes corresponding Graph/Chart)
Therapeutic Apheresis Registers Strong Growth
Table 36: US Market for Apheresis Equipment (2015E): Percentage Share Breakdown of Revenues Generated Through Procedures by Therapeutic Area (includes corresponding Graph/Chart)
Competitive Scenario
Table 37: Leading Players in the US Automated Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Fresenius, Haemonetics, and Terumo (includes corresponding Graph/Chart)
Table 38: Leading Players in the US Whole Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Fresenius, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)
Table 39: Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders (2013): Percentage Share Breakdown of Revenues for Fresenius Kabi, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart)
Table 40: Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders (2013): Percentage Share Breakdown of Number of Procedures for Fresenius Kabi, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart)
Table 41: Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2013): Percentage Share Breakdown of Revenues for Fresenius Kabi, Terumo BCT, Therakos, and Others (includes corresponding Graph/Chart)
Table 42: Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2013): Percentage Share Breakdown of Number of Procedures for Fresenius Kabi, Terumo BCT, and Others (includes corresponding Graph/Chart)
Trima Accel, the Most Widely Used Platelet Collection Equipment in the US
Consolidation of Blood Collectors and Healthcare Providers Puts Pricing Pressure on Suppliers
Implications of Healthcare Reforms
An Overview of Regulatory Environment and Reimbursement Scenario
Reimbursement Policies to Create Growth Opportunities for Therapeutic Apheresis
Medicaid Coverage for Therapeutic Apheresis by Various Conditions
Medicaid Coverage for Therapeutic Plasma Exchange
Medicaid covers therapeutic Cytapheresis for the following conditions:
Medicaid covers Extracorporeal Photopheresis (ECP) for the following conditions
Table 43: Payment Rates for Apheresis Procedures in 2013 & 2014 (In US$) (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 44: US Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 45: US Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 46: US 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current & Future Analysis
Product Approval
B.Market Analytics
Table 47: Canadian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 48: Canadian Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 49: Canadian 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current & Future Analysis
Therapeutic Apheresis Market
An Overview
Growing Demand for Cancer Treatments Drives Plateletpheresis Market
Key Statistics
Table 50: Leading Companies in the Japanese Whole Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Kawasumi and Terumo (includes corresponding Graph/Chart)
Table 51: Leading Companies in the Japanese Automated Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Terumo and Haemonetics (includes corresponding Graph/Chart)
Select Players
B.Market Analytics
Table 52: Japanese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 53: Japanese Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 54: Japanese 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current & Future Analysis
Blood Banking in Europe
Table 55: Leading Players in the European Whole Blood Collection Market (2013): Percentage Share Breakdown of Volume Sales for Fresenius, MacoPharma, Terumo and Others (includes corresponding Graph/Chart)
Table 56: Leading Players in the European Automated Blood Collection Market (2013E): Percentage Share Breakdown of Volume Sales for Fresenius, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)
B.Market Analytics
Table 57: European Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region
France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 58: European Historic Review for Apheresis Equipment by Geographic Region
France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 59: European 14-Year Perspective for Apheresis Equipment by Geographic Region
Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 60: European Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 61: European Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 62: European 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE
Market Analysis
Table 63: French Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 64: French Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 65: French 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY
A.Market Analysis
Current & Future Analysis
Select Players
B.Market Analytics
Table 66: German Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 67: German Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 68: German 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY
A.Market Analysis
Current & Future Analysis
Medica Spa
A Select Player
B.Market Analytics
Table 69: Italian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 70: Italian Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 71: Italian 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM
Market Analysis
Table 72: UK Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 73: UK Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 74: UK 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN
Market Analysis
Table 75: Spanish Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 76: Spanish Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 77: Spanish 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4f. REST OF EUROPE
Market Analysis
Table 78: Rest of Europe Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 79: Rest of Europe Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 80: Rest of Europe 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
Market Analysis
Table 81: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region
Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 82: Asia-Pacific Historic Review for Apheresis Equipment by Geographic Region
Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 83: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Geographic Region
Percentage Breakdown of Dollar Sales for Australia, China and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 84: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 85: Asia-Pacific Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 86: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. AUSTRALIA
A.Market Analysis
Strategic Corporate Development
B.Market Analytics
Table 87: Australian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 88: Australian Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 89: Australian 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5b. CHINA
Market Analysis
Table 90: Chinese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 91: Chinese Historic Review for Apheresis Equipment by Segment -Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 92: Chinese 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC
A.Market Analysis
Strategic Corporate Development
B.Market Analytics
Table 93: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 94: Rest of Asia-Pacific Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 95: Rest of Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. REST OF WORLD
A.Market Analysis
Current & Future Analysis
Strategic Corporate Development
B.Market Analytics
Table 96: Rest of World Recent Past, Current & Future Analysis for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 97: Rest of World Historic Review for Apheresis Equipment by Segment
Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 98: Rest of World 14-Year Perspective for Apheresis Equipment by Segment
Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 14 (including Divisions/Subsidiaries - 21)
The United States (9)
Japan (3)
Europe (9)
- Germany (6)
- Italy (3)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

STILLE Surgical Instruments Alcon Incorporated Hoya Surgical Optics, Inc. Hollister Inc. PerkinElmer, Inc. Cyberonics, Inc.